In non-small cell lung cancer (NSCLC) and urothelial cancer, TNFAIP2 is significantly correlated with cisplatin resistance, but the underlying mechanism needs to be explored [19, 20]. This evidence concerns the gene TNFAIP2 and non-small cell lung carcinoma.